GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH
Graphite Bio, Inc. (GRPH)
NASDAQ:AMEX Investor Relations:
alabamagraphite.com/investors-page
Company Research
Source: Business Wire
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Graphite Bio, Inc. (NasdaqGM: GRPH) with LENZ Therapeutics. Under the terms of the proposed transaction, Graphite shareholders will end up owning approximately 35% of the combined company, subject to possible adjustment. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://ksfcounsel.com/cases/nasdaqgm-grph/ to learn more.To learn more about KSF, whose partners include the Former Louisiana Attorney
Show less
Read more
Impact Snapshot
Event Time:
GRPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRPH alerts
High impacting Graphite Bio, Inc. news events
Weekly update
A roundup of the hottest topics
GRPH
News
- LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress [Yahoo! Finance]Yahoo! Finance
- Graphite Bio, SCWorx, Acurx Pharmaceuticals among healthcare movers [Seeking Alpha]Seeking Alpha
- Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics [Yahoo! Finance]Yahoo! Finance
- Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz TherapeuticsBusiness Wire
- Kuehn Law Encourages DSKE, RYZB, ROVR, and GRPH Investors to Contact Law FirmGlobeNewswire
GRPH
Earnings
- 11/13/23 - Miss
GRPH
Sec Filings
- 3/22/24 - Form 8-K
- 3/19/24 - Form 8-K
- 3/15/24 - Form SEC
- GRPH's page on the SEC website